Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
Retrieved on:
Friday, May 3, 2024
The agreement combines the Laminar flow-based gentle liquid exchange technology known as C-FREE™ technology from Curiox with the comprehensive suite of DURAClone dry pre-formulated antibody panels and customized DURA Innovations dry reagent antibody cocktails from Beckman Coulter Life Sciences.
Key Points:
- The agreement combines the Laminar flow-based gentle liquid exchange technology known as C-FREE™ technology from Curiox with the comprehensive suite of DURAClone dry pre-formulated antibody panels and customized DURA Innovations dry reagent antibody cocktails from Beckman Coulter Life Sciences.
- This workflow solution overcomes longstanding challenges faced by researchers worldwide, including the need for highly standardized, reproducible, and automated sample preparation for flow cytometry laboratories.
- "Our alliance with Beckman Coulter Life Sciences is not just about combining technologies; it's about combining our strengths to empower the scientific community," said Namyong Kim.
- "This partnership presents an exciting step forward in redefining the standards of quality and efficiency in flow cytometry research.